SureTrader Nadex Advertisement
Home > Boards > US Listed > Medical - Drugs >

Merck & Co. Inc. (MRK)

MRK RSS Feed
Add MRK Price Alert      Hide Sticky   Hide Intro
Moderator: DewDiligence
Search This Board: 
Last Post: 2/24/2017 11:46:39 AM - Followers: 31 - Board type: Free - Posts Today: 0
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
MRK
Current Price
Volume:
Bid Ask Day's Range
SureTrader
MRK News: In First Phase 3 Trial, Merck’s Investigational Inactivated Varicella Zoster Virus Vaccine (V212) Reduced the Incidence of ... 02/24/2017 04:00:00 PM
MRK News: Merck Receives Positive CHMP Opinion for New Pergoveris® Fertility Pen 02/24/2017 08:32:00 AM
MRK News: Current Report Filing (8-k) 02/23/2017 05:12:05 PM
MRK News: Merck’s Fight Against Infectious Disease Goes Digital with Launch of ILÚM Health Solutions 02/16/2017 08:00:00 AM
MRK News: Statement of Changes in Beneficial Ownership (4) 02/15/2017 11:31:17 AM
PostSubject
#300  Sticky Note MRK reports 4Q16 results: DewDiligence 02/02/17 09:36:54 AM
#307   This is more than a mere accounting adjustment, DewDiligence 02/24/17 11:46:39 AM
#306   Merck & Co., Inc. (NYSE:MRK) In $2.9 Billion trendmkr 02/24/17 11:14:11 AM
#305   MRK effectively discontinues MK-3682, the HCV nucleoside obtained DewDiligence 02/23/17 06:52:11 PM
#304   MRK’s BACE Inhibitor for AD fails in mild-to-moderate DewDiligence 02/14/17 05:12:01 PM
#303   Net sales for Sivextro in 2016 were $14 jamtomorrow2 02/03/17 04:32:01 PM
#302   MRK appears to have a threshold of $500M DewDiligence 02/02/17 07:14:53 PM
#301   Sivextro sales 2016. As a Trius CVR jamtomorrow2 02/02/17 07:10:45 PM
#300   MRK reports 4Q16 results: DewDiligence 02/02/17 09:36:54 AM
#298   Bristol-Myers Squibb To Share In Sales Of Merck trendmkr 01/24/17 08:51:48 PM
#297   Merck & Co., Inc. And Palantir Technologies Inc trendmkr 01/18/17 11:28:13 AM
#296   Bryan, Garnier & Co started Merck & Co ValueInvestor15 01/13/17 02:09:40 PM
#295   MRK & NLNK ebola vax inventor now Chairman remind2 01/03/17 11:36:46 PM
#294   CHMP approves MRK’s Keytruda in first-line NSCLC with DewDiligence 12/17/16 11:03:34 AM
#293   More on same topic—(MRK-GILD patent case): #msg-127266273. DewDiligence 12/17/16 10:42:43 AM
#292   Court orders GILD to pay MRK $2.54B in DewDiligence 12/15/16 05:16:41 PM
#291   GILD-MRK jury trial on Sovaldi patent starts 12/5/16: DewDiligence 11/28/16 11:29:50 AM
#290   MRK’s 3-DAA HCV regimen fails to impress: #msg-126517784. DewDiligence 11/13/16 10:44:55 AM
#289   Yes sir. I'm lookin at TLTF* they are 123414 10/28/16 12:05:11 PM
#285   Let's just see where the profits are going. pennystockaholic 10/28/16 04:04:18 AM
#284   Insider Trading News: Insiders at the company look 123414 10/26/16 06:07:02 AM
#283   FDA approves Keytruda in first-line NSCLC: #msg-126020834. DewDiligence 10/24/16 06:43:57 PM
#282   Keytruda bests chemo in second-line bladder cancer: #msg-125948230. DewDiligence 10/21/16 08:09:28 AM
#281   Merck $MRK upgraded by Bank of America to ValueInvestor15 10/13/16 04:01:26 PM
#280   Merck, Bristol-Myers Squibb Present Results From Anti-PD-1 Drug trendmkr 10/13/16 11:16:08 AM
#279   MRK ESMO slides: DewDiligence 10/09/16 04:05:43 PM
#278   MERCK (MRK), good new's! Norton1973 10/07/16 07:21:06 PM
#277   PDUFA date for Keytruda in first-line NSCLC is DewDiligence 09/07/16 10:55:37 AM
#276   MRK discontinues Odanacatib program due to stroke risk: #msg-124932073. DewDiligence 09/02/16 09:49:51 AM
#273   Inside the FDA Ebola Edition: Frontrunners Merck, GlaxoSmithKline nyctraydr 08/25/16 01:16:38 PM
#272   Development of strategies to address primary resistance and TERIA 08/19/16 06:30:46 AM
#271   Merck & Co Slashes 148 Jobs http://marketexclusive.com/merck-co-inc-nysemrk-sl nyctraydr 08/17/16 01:29:24 PM
#270   MRK throws in the towel on Zontivity: DewDiligence 08/16/16 10:29:24 AM
#269   That is not chump change - even for DewDiligence 08/16/16 09:15:42 AM
#268   Wow! That is not chump change - K The New Investor 08/16/16 08:23:18 AM
#267   MRK’s CEO and EVP sold $24.5M of stock DewDiligence 08/13/16 11:21:36 AM
#266   Musings on BMY's CHECKPOINT-026 trial: #msg-124358375. DewDiligence 08/06/16 12:52:18 PM
#265   News: EU approval: http://ih.advfn.com/p.php?pid=nmona&article=72118975 crudeoil24 08/02/16 05:30:23 PM
#264   2Q16 Harvoni/Viekira/Zepatier sales in US/EU/Japan: #msg-124194472. DewDiligence 07/29/16 02:35:00 PM
#263   Merck To Cut Jobs In R&D While Increasing venturecapp 07/14/16 01:40:56 PM
#262   Merck Group give case study insight into emerging TERIA 07/12/16 12:00:49 PM
#261   http://www.nbcnews.com/health/cancer/lung-cancer-trial-stopped-after-jimmy- JoeRoganFan 07/05/16 09:24:57 PM
#260   CHMP approves MRK’s Keytruda in second-line NSCLC with DewDiligence 06/27/16 10:07:32 AM
#259   Keytruda succeeds in first-line NSCLC: #msg-123339268. DewDiligence 06/16/16 03:33:55 PM
#258   ;-) Cbdpotential 06/16/16 03:31:40 PM
#257   Merck, Pfizer, Eye Cannabis Acquisitions nyctraydr 06/15/16 10:41:28 AM
#256   Oh snap! Adding JoeRoganFan 06/08/16 11:12:50 PM
#255   I'm up 9% from when I bought 12-21. JoeRoganFan 06/04/16 12:00:48 AM
#254   Good news Cbdpotential 05/23/16 09:58:31 AM
#253   Nice! Good luck :-D Cbdpotential 05/09/16 11:10:22 AM
#252   I joined you this morning, in at 53.80. brharris 05/09/16 10:45:35 AM
PostSubject